Toronto, Canada, June 20 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD”) a federally-licensed producer and distributor of medical cannabis, is pleased to announce it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart. Subject to Health Canada's approval of Shoppers Drug Mart's application...
Throughout Canada, the United States and internationally, therapeutic use of cannabis is increasing among patients supported by a growing consensus of medical professionals. Since doctors are generally trained to practice evidence-based medicine, the amount of research and development going into collecting clinical data and the...
Toronto, Canada, June 14, 2018 – Hiku Brands Company Ltd. (“Hiku”) (CSE:HIKU) and WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD”) are pleased to announce that WeedMD has obtained an interim order from the Ontario Superior Court of Justice authorizing the holding of an annual and special meeting (the “WeedMD Meeting”)...
Toronto, Canada, June 13, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD”), a federally-licensed producer and distributor of medical cannabis, and Revive Therapeutics Ltd. (TSX-V:RVV) (OTCQB:RVVTF) (FSE:31R) (“Revive”), a company focused on the research, development and commercialization of novel cannabinoid-based therapies, are pleased to announce...
Toronto, Canada, June 11, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that it has secured its Health Canada Cultivation Licence for the first four grow rooms within its 220,000 sq. ft....
Toronto, Canada, May 31, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, has reported its financial and operating results for the first quarter ending March 31, 2018. WeedMD is pleased to report revenues of $1.14 million...
Toronto, Canada, May 1, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, has announced its financial results for the fourth quarter and fiscal year ending December 31, 2017. WeedMD is pleased to report revenue of $1.4...
Introducing Josephine DesLauriers. She joined our team recently as the Vice President of People and her role will be integral as we scale for growth, amplify our recruitment drive and prepare for our pending merger with Hiku Brands. Josephine brings a refreshing outlook and strategic vision...
The Transaction combines a premium cannabis brand house and retail focused operator in Hiku, with the significant production capabilities and differentiated medical brand in WeedMD Vertically integrated operations secure control over the entire cannabis value chain Coast-to-coast and diversified cannabis cultivation platform with four...
Toronto, Canada, March 27, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board....
To help ensure our patients are up to date with all procedures and measures being taken during this time, we have created a website specific to WeedMD and COVID-19 updates.
VISIT PAGE NOW